Pharma stocks rally in listless trading

Other gainers from the sector were Cipla, Ranbaxy Laboratories and Lupin. Analysts attribute the gains in pharma stocks to renewed investor interest following better growth prospects and also hedging against any likely fall in the markets.
Pharma stocks are defensive stocks and hence do not fall, during a sharp decline in the markets.
GoodReturns.in


Click it and Unblock the Notifications



